Company Search:
Advanced Search
Sponsored Links
Medlab Clinical Ltd Company Snapshot
Medlab Clinical Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medlab Clinical Ltd with three other companies in this sector in AUSTRALIA : Cellmid Limited (2021 sales of 5.82 million Australian Dollars [US$4.24 million] of which 75% was Advangen Japan), Paradigm Biopharmaceuticals Ltd (8.94 million Australian Dollars [US$6.52 million] of which 100% was Research and development of pharmaceutic), and Exopharm Ltd (4.19 million Australian Dollars [US$3.05 million] ).

Sales Analysis. Medlab Clinical Ltd reported sales of A$6.69 million (US$4.88 million) for the fiscal year ending June of 2021. This represents an increase of 24.6% versus 2020, when the company's sales were A$5.37 million. Despite this increase, sales are still well below the level achieved in 2019, when Medlab Clinical Ltd reported sales of A$7.80 million. Sales of Corporate/ Other saw an increase that was more than double the company's growth rate: sales were up 4,759.4% in 2021, from A$76,142.00 to A$3.70 million. Medlab Clinical Ltd also saw significant increases in sales in Nutraceutical (up 70.4% to A$3.68 million) . Not all segments of Medlab Clinical Ltd experienced an increase in sales in 2021: sales of Pharmaceutical Research fell 79.1% to A$747,747.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medlab Clinical Ltd
  Stock Performance Chart for Medlab Clinical Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): .17
(Figures in Australian Dollars)
1 Week -8.3%   13 Weeks -8.3%  
4 Weeks 6.5%   52 Weeks -5.7%  
Medlab Clinical Ltd Key Data:
  Ticker: MDC Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 6,689,610
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 56,458,986
  Fiscal Yr Ends: June Shares Outstanding: 342,175,671
  Share Type: Ordinary Closely Held Shares: 147,015,245
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.